Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (10)

2024

  1. Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model

    Journal for immunotherapy of cancer, Vol. 12, Núm. 7

2022

  1. Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 8

2021

  1. SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation

    Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 3

2020

  1. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient

    British Journal of Dermatology, Vol. 182, Núm. 5, pp. 1194-1204

2017

  1. Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)

    PLoS ONE, Vol. 12, Núm. 9

2011

  1. Improved dendritic cell-based immunization against hepatitis C virus using peptide inhibitors of interleukin 10

    Hepatology, Vol. 53, Núm. 1, pp. 23-31

2005

  1. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex

    Vaccine, Vol. 23, Núm. 11, pp. 1384-1392

2002

  1. Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigen

    Clinical Cancer Research, Vol. 8, Núm. 10, pp. 3219-3225

1998

  1. Defective recombinant adenoviruses as a tool to induce anti-HCV immune responses

    Biotecnologia Aplicada, Vol. 15, Núm. 3, pp. 195

1997

  1. Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C

    Gastroenterology, Vol. 113, Núm. 5, pp. 1647-1653